Teng Moua

4.9k total citations
92 papers, 2.1k citations indexed

About

Teng Moua is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Teng Moua has authored 92 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 18 papers in Epidemiology. Recurrent topics in Teng Moua's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (64 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Occupational and environmental lung diseases (15 papers). Teng Moua is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (64 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Occupational and environmental lung diseases (15 papers). Teng Moua collaborates with scholars based in United States, Italy and Thailand. Teng Moua's co-authors include Jay H. Ryu, Andrew H. Limper, Tananchai Petnak, Brian J. Bartholmai, Charat Thongprayoon, Ronald A. Karwoski, Fabien Maldonado, Sushravya Raghunath, Thomas E. Hartman and Richard A. Robb and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Teng Moua

82 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teng Moua United States 25 1.6k 577 407 258 150 92 2.1k
David Milne New Zealand 23 1.4k 0.9× 477 0.8× 339 0.8× 78 0.3× 137 0.9× 62 2.0k
D.M. Hansell United Kingdom 24 1.8k 1.1× 589 1.0× 355 0.9× 491 1.9× 57 0.4× 47 2.1k
Anand Devaraj United Kingdom 26 2.5k 1.5× 585 1.0× 471 1.2× 849 3.3× 18 0.1× 73 3.2k
Carlos Leiva‐Salinas United States 23 390 0.2× 271 0.5× 373 0.9× 135 0.5× 41 0.3× 119 1.7k
Sara Piciucchi Italy 24 1.8k 1.2× 559 1.0× 170 0.4× 130 0.5× 25 0.2× 91 2.2k
Santiago E. Rossi United States 22 1.5k 0.9× 179 0.3× 515 1.3× 84 0.3× 23 0.2× 44 2.5k
Nesrin Moğulkoç Türkiye 19 1.2k 0.8× 375 0.6× 210 0.5× 66 0.3× 32 0.2× 61 1.6k
Julien Guiot Belgium 26 1.1k 0.7× 259 0.4× 228 0.6× 245 0.9× 23 0.2× 111 2.2k
Susan J. Copley United Kingdom 24 2.3k 1.4× 739 1.3× 542 1.3× 797 3.1× 13 0.1× 47 2.9k
Jae Seung Lee South Korea 22 888 0.6× 225 0.4× 111 0.3× 35 0.1× 101 0.7× 133 1.5k

Countries citing papers authored by Teng Moua

Since Specialization
Citations

This map shows the geographic impact of Teng Moua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Moua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Moua more than expected).

Fields of papers citing papers by Teng Moua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng Moua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Moua. The network helps show where Teng Moua may publish in the future.

Co-authorship network of co-authors of Teng Moua

This figure shows the co-authorship network connecting the top 25 collaborators of Teng Moua. A scholar is included among the top collaborators of Teng Moua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Moua. Teng Moua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moua, Teng & Roberto Benzo. (2025). Home-based pulmonary rehabilitation and health coaching in fibrotic interstitial lung disease: a perspective on current evidence and future directions. Expert Review of Respiratory Medicine. 20(2). 121–131. 1 indexed citations
3.
Petnak, Tananchai, et al.. (2024). Diagnosis of renal tumors in Birt-Hogg-Dube syndrome: Clinical presentation and risk factors in a single-center retrospective cohort. BMC Nephrology. 25(1). 329–329. 1 indexed citations
4.
Petnak, Tananchai, et al.. (2024). Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis. Respiratory Research. 25(1). 2 indexed citations
5.
Matson, Scott M., Misbah Baqir, Teng Moua, et al.. (2022). Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease. CHEST Journal. 163(4). 861–869. 43 indexed citations
6.
Wijsenbeek, Marlies, María Molina‐Molina, Olivier Chassany, et al.. (2022). Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Research. 8(2). 681–2021. 10 indexed citations
7.
Williams, James, Grace Liu, Ananya Panda, et al.. (2022). Predicting Usual Interstitial Pneumonia Histopathology From Chest CT Imaging With Deep Learning. CHEST Journal. 162(4). 815–823. 29 indexed citations
8.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2021). Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. European Respiratory Journal. 59(3). 2004538–2004538. 65 indexed citations
10.
Moua, Teng, Paul J. Novotny, Jennifer L. Ridgeway, et al.. (2021). Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect. ERJ Open Research. 7(1). 11–2021. 1 indexed citations
11.
Koslow, Matthew, Eric S. Edell, David E. Midthun, et al.. (2020). Bronchoscopic Cryobiopsy and Forceps Biopsy for the Diagnostic Evaluation of Diffuse Parenchymal Lung Disease in Clinical Practice. SHILAP Revista de lepidopterología. 4(5). 565–574. 14 indexed citations
12.
Gao, Yang, et al.. (2020). Dendriform pulmonary ossification complicated by recurrent spontaneous pneumothorax: Two case reports and a review of the literature. Respiratory Medicine Case Reports. 30. 101067–101067. 4 indexed citations
13.
Giacomi, Federica De, Faria Nasim, Chi Wan Koo, et al.. (2018). Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival. Respiratory Medicine. 146. 106–112. 32 indexed citations
14.
Moraes, Alice Gallo de, et al.. (2016). Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity. Respiratory Medicine. 118. 53–57. 9 indexed citations
15.
Zamora, Ana, Sumedh S. Hoskote, Beatriz Abascal-Bolado, et al.. (2016). Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respiratory Medicine. 118. 39–45. 63 indexed citations
16.
Moua, Teng, et al.. (2016). Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening. CHEST Journal. 149(5). 1205–1214. 81 indexed citations
17.
Moraes, Alice Gallo de, et al.. (2015). Acute fever and seizure in a patient with recent atrial fibrillation ablation. Heart & Lung. 44(4). 314–316. 2 indexed citations
18.
Thakur, Lokendra, et al.. (2014). Reducing Urinary Catheter Days and Utilization in a Chronic Ventilator Dependent Unit: Mayo Clinic Quality Improvement Experience. CHEST Journal. 146(4). 556A–556A. 1 indexed citations
19.
Carmona, Eva M., Theodore J. Kottom, Deanne Hebrink, et al.. (2012). Glycosphingolipids Mediate Pneumocystis Cell Wall β-Glucan Activation of the IL-23/IL-17 Axis in Human Dendritic Cells. American Journal of Respiratory Cell and Molecular Biology. 47(1). 50–59. 36 indexed citations
20.
Moua, Teng, Kenneth E. Wood, Brett D. Atwater, & James Runo. (2008). Major Pulmonary Embolism and Hemodynamic Stability from Shunting Through a Patent Foramen Ovale. Southern Medical Journal. 101(9). 955–958. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026